Delaet Ingrid sold NBIX
May 29, 2026 · Form 4 insider transaction
Delaet Ingrid sold 2,261 shares of Neurocrine Biosciences, Inc. at $156.71 per share, a transaction worth $354.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,261
Price
$156.71
Total value
$354.3K
InsiderDelaet Ingrid
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 29, 2026
Filing dateJune 2, 2026
Shares owned after16,225
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.